Global Postpartum Haemorrhage Devices Market
Global Postpartum Haemorrhage Devices Market

Postpartum Haemorrhage Devices Comprehensive Study by Type (Uterine Balloon Tamponade (Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon), Uniject Prefilled Injection System, Non-Pneumatic Anti-Shock Garment), Application (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026

Postpartum Haemorrhage Devices Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 244 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Postpartum Haemorrhage Devices Market Scope?
Postpartum hemorrhage is defined as blood loss of more than 500 ml from the genital tract within 24 hours of the vaginal birth of a baby or 1,000 ml or more after cesarean delivery. Rapid, efficient action must be taken to save the woman‘s life and to prevent complications related to significant blood loss. The potential significance of these effects is increased in the presence of chronic anemia and in women with chronic health problems including HIV/AIDS, malaria, hookworm, hemoglobinopathies, and tuberculosis. Postpartum hemorrhage (PPH) is the world‘s leading cause of maternal mortality, accounting for one-third of all maternal deaths worldwide. PPH causes up to 60% of all maternal deaths in developing countries. The majority of these deaths occur within 4 hours of delivery, indicating they are a consequence of events in the third stage of labor. These are the devices that are used to treat the PPH. PPH devices are the equipment that is used to manage or limit uterine blood loss during PPH. The demand for postpartum hemorrhage devices has increased owing to the rise in the number of complications during pregnancy. Also, there has been a huge demand for advanced healthcare services and technology in the forecasted period.

The Postpartum Haemorrhage Devices market study is being classified by Type (Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon], Uniject Prefilled Injection System and Non-Pneumatic Anti-Shock Garment), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Postpartum Haemorrhage Devices market throughout the predicted period.

Utah Medical Products, Inc. (United States), C. R. Bard, Inc. (United States ), Cook Medical, Inc. (United States), Becton (United States), Dickinson, and Company (United States), Teleflex Incorporated (United States), Bactiguard AB (Sweden), Program for Appropriate Technology in Health (PATH) (United States), 3RD Stone Design, Inc (United States), Zoex Niasg (United States) and Vitality Medical (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Revmedx Inc (United States) and Inpress Technologies (Canada).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Postpartum Haemorrhage Devices market by Type, Application and Region.

On the basis of geography, the market of Postpartum Haemorrhage Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Increasing Need for Improved Health Care Instruments

Market Drivers
  • The Rise in the Cases of Postpartum Haemorrhage
  • Increasing Birth Rate
  • Growing Pregnancy Complications

Opportunities
  • Increasing Education Programs and Awareness Towards the Complications
  • An Upsurge in Technological Developments

Restraints
  • High Cost of Devices

Challenges
  • Lack of Trained and Skilled Professionals


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Postpartum Haemorrhage Devices, Suppliers and Distributors of Postpartum Haemorrhage Devices, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon]
  • Uniject Prefilled Injection System
  • Non-Pneumatic Anti-Shock Garment
By Application
  • Hospitals
  • Clinics
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rise in the Cases of Postpartum Haemorrhage
      • 3.2.2. Increasing Birth Rate
      • 3.2.3. Growing Pregnancy Complications
    • 3.3. Market Challenges
      • 3.3.1. Lack of Trained and Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Need for Improved Health Care Instruments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Postpartum Haemorrhage Devices, by Type, Application and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Postpartum Haemorrhage Devices (Value)
      • 5.2.1. Global Postpartum Haemorrhage Devices by: Type (Value)
        • 5.2.1.1. Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon]
        • 5.2.1.2. Uniject Prefilled Injection System
        • 5.2.1.3. Non-Pneumatic Anti-Shock Garment
      • 5.2.2. Global Postpartum Haemorrhage Devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Postpartum Haemorrhage Devices Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Postpartum Haemorrhage Devices (Volume)
      • 5.3.1. Global Postpartum Haemorrhage Devices by: Type (Volume)
        • 5.3.1.1. Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon]
        • 5.3.1.2. Uniject Prefilled Injection System
        • 5.3.1.3. Non-Pneumatic Anti-Shock Garment
      • 5.3.2. Global Postpartum Haemorrhage Devices by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Others
      • 5.3.3. Global Postpartum Haemorrhage Devices Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Postpartum Haemorrhage Devices (Price)
      • 5.4.1. Global Postpartum Haemorrhage Devices by: Type (Price)
  • 6. Postpartum Haemorrhage Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Utah Medical Products, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. C. R. Bard, Inc. (United States )
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Medical, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dickinson, and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Teleflex Incorporated (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bactiguard AB (Sweden)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Program for Appropriate Technology in Health (PATH) (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. 3RD Stone Design, Inc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Zoex Niasg (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Vitality Medical (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Postpartum Haemorrhage Devices Sale, by Type, Application and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Postpartum Haemorrhage Devices (Value)
      • 7.2.1. Global Postpartum Haemorrhage Devices by: Type (Value)
        • 7.2.1.1. Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon]
        • 7.2.1.2. Uniject Prefilled Injection System
        • 7.2.1.3. Non-Pneumatic Anti-Shock Garment
      • 7.2.2. Global Postpartum Haemorrhage Devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Postpartum Haemorrhage Devices Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Postpartum Haemorrhage Devices (Volume)
      • 7.3.1. Global Postpartum Haemorrhage Devices by: Type (Volume)
        • 7.3.1.1. Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon]
        • 7.3.1.2. Uniject Prefilled Injection System
        • 7.3.1.3. Non-Pneumatic Anti-Shock Garment
      • 7.3.2. Global Postpartum Haemorrhage Devices by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Others
      • 7.3.3. Global Postpartum Haemorrhage Devices Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Postpartum Haemorrhage Devices (Price)
      • 7.4.1. Global Postpartum Haemorrhage Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Postpartum Haemorrhage Devices: by Type(USD Million)
  • Table 2. Postpartum Haemorrhage Devices Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon] , by Region USD Million (2015-2020)
  • Table 3. Postpartum Haemorrhage Devices Uniject Prefilled Injection System , by Region USD Million (2015-2020)
  • Table 4. Postpartum Haemorrhage Devices Non-Pneumatic Anti-Shock Garment , by Region USD Million (2015-2020)
  • Table 5. Postpartum Haemorrhage Devices: by Application(USD Million)
  • Table 6. Postpartum Haemorrhage Devices Hospitals , by Region USD Million (2015-2020)
  • Table 7. Postpartum Haemorrhage Devices Clinics , by Region USD Million (2015-2020)
  • Table 8. Postpartum Haemorrhage Devices Others , by Region USD Million (2015-2020)
  • Table 9. South America Postpartum Haemorrhage Devices, by Country USD Million (2015-2020)
  • Table 10. South America Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 11. South America Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 12. Brazil Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 13. Brazil Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 14. Argentina Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 15. Argentina Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 16. Rest of South America Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 18. Asia Pacific Postpartum Haemorrhage Devices, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 21. China Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 22. China Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 23. Japan Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 24. Japan Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 25. India Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 26. India Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 27. South Korea Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 28. South Korea Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 29. Taiwan Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 30. Taiwan Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 31. Australia Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 32. Australia Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 35. Europe Postpartum Haemorrhage Devices, by Country USD Million (2015-2020)
  • Table 36. Europe Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 37. Europe Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 38. Germany Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 39. Germany Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 40. France Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 41. France Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 42. Italy Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 43. Italy Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 44. United Kingdom Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 46. Netherlands Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 47. Netherlands Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 48. Rest of Europe Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 50. MEA Postpartum Haemorrhage Devices, by Country USD Million (2015-2020)
  • Table 51. MEA Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 52. MEA Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 53. Middle East Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 54. Middle East Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 55. Africa Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 56. Africa Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 57. North America Postpartum Haemorrhage Devices, by Country USD Million (2015-2020)
  • Table 58. North America Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 59. North America Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 60. United States Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 61. United States Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 62. Canada Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 63. Canada Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 64. Mexico Postpartum Haemorrhage Devices, by Type USD Million (2015-2020)
  • Table 65. Mexico Postpartum Haemorrhage Devices, by Application USD Million (2015-2020)
  • Table 66. Postpartum Haemorrhage Devices Sales: by Type(K Units)
  • Table 67. Postpartum Haemorrhage Devices Sales Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon] , by Region K Units (2015-2020)
  • Table 68. Postpartum Haemorrhage Devices Sales Uniject Prefilled Injection System , by Region K Units (2015-2020)
  • Table 69. Postpartum Haemorrhage Devices Sales Non-Pneumatic Anti-Shock Garment , by Region K Units (2015-2020)
  • Table 70. Postpartum Haemorrhage Devices Sales: by Application(K Units)
  • Table 71. Postpartum Haemorrhage Devices Sales Hospitals , by Region K Units (2015-2020)
  • Table 72. Postpartum Haemorrhage Devices Sales Clinics , by Region K Units (2015-2020)
  • Table 73. Postpartum Haemorrhage Devices Sales Others , by Region K Units (2015-2020)
  • Table 74. South America Postpartum Haemorrhage Devices Sales, by Country K Units (2015-2020)
  • Table 75. South America Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 76. South America Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 77. Brazil Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 78. Brazil Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 79. Argentina Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 80. Argentina Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 81. Rest of South America Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 82. Rest of South America Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 83. Asia Pacific Postpartum Haemorrhage Devices Sales, by Country K Units (2015-2020)
  • Table 84. Asia Pacific Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 85. Asia Pacific Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 86. China Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 87. China Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 88. Japan Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 89. Japan Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 90. India Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 91. India Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 92. South Korea Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 93. South Korea Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 94. Taiwan Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 95. Taiwan Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 96. Australia Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 97. Australia Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 98. Rest of Asia-Pacific Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 99. Rest of Asia-Pacific Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 100. Europe Postpartum Haemorrhage Devices Sales, by Country K Units (2015-2020)
  • Table 101. Europe Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 102. Europe Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 103. Germany Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 104. Germany Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 105. France Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 106. France Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 107. Italy Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 108. Italy Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 109. United Kingdom Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 110. United Kingdom Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 111. Netherlands Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 112. Netherlands Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 113. Rest of Europe Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 114. Rest of Europe Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 115. MEA Postpartum Haemorrhage Devices Sales, by Country K Units (2015-2020)
  • Table 116. MEA Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 117. MEA Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 118. Middle East Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 119. Middle East Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 120. Africa Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 121. Africa Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 122. North America Postpartum Haemorrhage Devices Sales, by Country K Units (2015-2020)
  • Table 123. North America Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 124. North America Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 125. United States Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 126. United States Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 127. Canada Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 128. Canada Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 129. Mexico Postpartum Haemorrhage Devices Sales, by Type K Units (2015-2020)
  • Table 130. Mexico Postpartum Haemorrhage Devices Sales, by Application K Units (2015-2020)
  • Table 131. Postpartum Haemorrhage Devices: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Postpartum Haemorrhage Devices: by Type(USD Million)
  • Table 144. Postpartum Haemorrhage Devices Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon] , by Region USD Million (2021-2026)
  • Table 145. Postpartum Haemorrhage Devices Uniject Prefilled Injection System , by Region USD Million (2021-2026)
  • Table 146. Postpartum Haemorrhage Devices Non-Pneumatic Anti-Shock Garment , by Region USD Million (2021-2026)
  • Table 147. Postpartum Haemorrhage Devices: by Application(USD Million)
  • Table 148. Postpartum Haemorrhage Devices Hospitals , by Region USD Million (2021-2026)
  • Table 149. Postpartum Haemorrhage Devices Clinics , by Region USD Million (2021-2026)
  • Table 150. Postpartum Haemorrhage Devices Others , by Region USD Million (2021-2026)
  • Table 151. South America Postpartum Haemorrhage Devices, by Country USD Million (2021-2026)
  • Table 152. South America Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 153. South America Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 154. Brazil Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 155. Brazil Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 156. Argentina Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 157. Argentina Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 158. Rest of South America Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 159. Rest of South America Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 160. Asia Pacific Postpartum Haemorrhage Devices, by Country USD Million (2021-2026)
  • Table 161. Asia Pacific Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 162. Asia Pacific Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 163. China Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 164. China Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 165. Japan Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 166. Japan Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 167. India Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 168. India Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 169. South Korea Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 170. South Korea Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 171. Taiwan Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 172. Taiwan Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 173. Australia Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 174. Australia Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 175. Rest of Asia-Pacific Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 176. Rest of Asia-Pacific Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 177. Europe Postpartum Haemorrhage Devices, by Country USD Million (2021-2026)
  • Table 178. Europe Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 179. Europe Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 180. Germany Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 181. Germany Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 182. France Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 183. France Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 184. Italy Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 185. Italy Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 186. United Kingdom Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 187. United Kingdom Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 188. Netherlands Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 189. Netherlands Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 190. Rest of Europe Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 191. Rest of Europe Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 192. MEA Postpartum Haemorrhage Devices, by Country USD Million (2021-2026)
  • Table 193. MEA Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 194. MEA Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 195. Middle East Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 196. Middle East Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 197. Africa Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 198. Africa Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 199. North America Postpartum Haemorrhage Devices, by Country USD Million (2021-2026)
  • Table 200. North America Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 201. North America Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 202. United States Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 203. United States Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 204. Canada Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 205. Canada Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 206. Mexico Postpartum Haemorrhage Devices, by Type USD Million (2021-2026)
  • Table 207. Mexico Postpartum Haemorrhage Devices, by Application USD Million (2021-2026)
  • Table 208. Postpartum Haemorrhage Devices Sales: by Type(K Units)
  • Table 209. Postpartum Haemorrhage Devices Sales Uterine Balloon Tamponade [Foley Catheter, Condom Catheter, Bakri Balloon Tamponade, BT-Cath Balloon, Rusch Balloon] , by Region K Units (2021-2026)
  • Table 210. Postpartum Haemorrhage Devices Sales Uniject Prefilled Injection System , by Region K Units (2021-2026)
  • Table 211. Postpartum Haemorrhage Devices Sales Non-Pneumatic Anti-Shock Garment , by Region K Units (2021-2026)
  • Table 212. Postpartum Haemorrhage Devices Sales: by Application(K Units)
  • Table 213. Postpartum Haemorrhage Devices Sales Hospitals , by Region K Units (2021-2026)
  • Table 214. Postpartum Haemorrhage Devices Sales Clinics , by Region K Units (2021-2026)
  • Table 215. Postpartum Haemorrhage Devices Sales Others , by Region K Units (2021-2026)
  • Table 216. South America Postpartum Haemorrhage Devices Sales, by Country K Units (2021-2026)
  • Table 217. South America Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 218. South America Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 219. Brazil Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 220. Brazil Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 221. Argentina Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 222. Argentina Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 223. Rest of South America Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 224. Rest of South America Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 225. Asia Pacific Postpartum Haemorrhage Devices Sales, by Country K Units (2021-2026)
  • Table 226. Asia Pacific Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 227. Asia Pacific Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 228. China Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 229. China Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 230. Japan Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 231. Japan Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 232. India Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 233. India Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 234. South Korea Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 235. South Korea Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 236. Taiwan Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 237. Taiwan Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 238. Australia Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 239. Australia Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 240. Rest of Asia-Pacific Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 241. Rest of Asia-Pacific Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 242. Europe Postpartum Haemorrhage Devices Sales, by Country K Units (2021-2026)
  • Table 243. Europe Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 244. Europe Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 245. Germany Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 246. Germany Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 247. France Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 248. France Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 249. Italy Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 250. Italy Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 251. United Kingdom Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 252. United Kingdom Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 253. Netherlands Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 254. Netherlands Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 255. Rest of Europe Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 256. Rest of Europe Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 257. MEA Postpartum Haemorrhage Devices Sales, by Country K Units (2021-2026)
  • Table 258. MEA Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 259. MEA Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 260. Middle East Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 261. Middle East Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 262. Africa Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 263. Africa Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 264. North America Postpartum Haemorrhage Devices Sales, by Country K Units (2021-2026)
  • Table 265. North America Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 266. North America Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 267. United States Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 268. United States Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 269. Canada Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 270. Canada Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 271. Mexico Postpartum Haemorrhage Devices Sales, by Type K Units (2021-2026)
  • Table 272. Mexico Postpartum Haemorrhage Devices Sales, by Application K Units (2021-2026)
  • Table 273. Postpartum Haemorrhage Devices: by Type(USD/Units)
  • Table 274. Research Programs/Design for This Report
  • Table 275. Key Data Information from Secondary Sources
  • Table 276. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Postpartum Haemorrhage Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Postpartum Haemorrhage Devices: by Application USD Million (2015-2020)
  • Figure 6. South America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 7. Asia Pacific Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 8. Europe Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 9. MEA Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 10. North America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 11. Global Postpartum Haemorrhage Devices: by Type K Units (2015-2020)
  • Figure 12. Global Postpartum Haemorrhage Devices: by Application K Units (2015-2020)
  • Figure 13. South America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 14. Asia Pacific Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 15. Europe Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 16. MEA Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 17. North America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 18. Global Postpartum Haemorrhage Devices: by Type USD/Units (2015-2020)
  • Figure 19. Global Postpartum Haemorrhage Devices share by Players 2020 (%)
  • Figure 20. Global Postpartum Haemorrhage Devices share by Players (Top 3) 2020(%)
  • Figure 21. Global Postpartum Haemorrhage Devices share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Utah Medical Products, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Utah Medical Products, Inc. (United States) Revenue: by Geography 2020
  • Figure 25. C. R. Bard, Inc. (United States ) Revenue, Net Income and Gross profit
  • Figure 26. C. R. Bard, Inc. (United States ) Revenue: by Geography 2020
  • Figure 27. Cook Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cook Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Becton (United States) Revenue, Net Income and Gross profit
  • Figure 30. Becton (United States) Revenue: by Geography 2020
  • Figure 31. Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 33. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 34. Teleflex Incorporated (United States) Revenue: by Geography 2020
  • Figure 35. Bactiguard AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 36. Bactiguard AB (Sweden) Revenue: by Geography 2020
  • Figure 37. Program for Appropriate Technology in Health (PATH) (United States) Revenue, Net Income and Gross profit
  • Figure 38. Program for Appropriate Technology in Health (PATH) (United States) Revenue: by Geography 2020
  • Figure 39. 3RD Stone Design, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 40. 3RD Stone Design, Inc (United States) Revenue: by Geography 2020
  • Figure 41. Zoex Niasg (United States) Revenue, Net Income and Gross profit
  • Figure 42. Zoex Niasg (United States) Revenue: by Geography 2020
  • Figure 43. Vitality Medical (United States) Revenue, Net Income and Gross profit
  • Figure 44. Vitality Medical (United States) Revenue: by Geography 2020
  • Figure 45. Global Postpartum Haemorrhage Devices: by Type USD Million (2021-2026)
  • Figure 46. Global Postpartum Haemorrhage Devices: by Application USD Million (2021-2026)
  • Figure 47. South America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 48. Asia Pacific Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 49. Europe Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 50. MEA Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 51. North America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 52. Global Postpartum Haemorrhage Devices: by Type K Units (2021-2026)
  • Figure 53. Global Postpartum Haemorrhage Devices: by Application K Units (2021-2026)
  • Figure 54. South America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 55. Asia Pacific Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 56. Europe Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 57. MEA Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 58. North America Postpartum Haemorrhage Devices Share (%), by Country
  • Figure 59. Global Postpartum Haemorrhage Devices: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Utah Medical Products, Inc. (United States)
  • C. R. Bard, Inc. (United States )
  • Cook Medical, Inc. (United States)
  • Becton (United States)
  • Dickinson, and Company (United States)
  • Teleflex Incorporated (United States)
  • Bactiguard AB (Sweden)
  • Program for Appropriate Technology in Health (PATH) (United States)
  • 3RD Stone Design, Inc (United States)
  • Zoex Niasg (United States)
  • Vitality Medical (United States)
Additional players considered in the study are as follows:
Revmedx Inc (United States) , Inpress Technologies (Canada)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation